These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 21207170

  • 1. Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
    Chua TC, Al-Zahrani A, Saxena A, Glenn D, Liauw W, Zhao J, Morris DL.
    Ann Surg Oncol; 2011 Jun; 18(6):1582-9. PubMed ID: 21207170
    [Abstract] [Full Text] [Related]

  • 2. A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.
    Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF.
    Ann Surg Oncol; 2015 Oct; 22(11):3640-6. PubMed ID: 25698402
    [Abstract] [Full Text] [Related]

  • 3. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL.
    J Clin Oncol; 2012 Jul 10; 30(20):2449-56. PubMed ID: 22614976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL.
    Br J Surg; 2006 Oct 10; 93(10):1270-6. PubMed ID: 16838392
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mucinous appendiceal neoplasms: classification, imaging, and HIPEC.
    Bartlett DJ, Thacker PG, Grotz TE, Graham RP, Fletcher JG, VanBuren WM, Iyer VR, Fidler JL, Menias CO, Wasif N, Sheedy SP.
    Abdom Radiol (NY); 2019 May 10; 44(5):1686-1702. PubMed ID: 30610247
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Appendiceal mucoceles, pseudomyxoma peritonei and appendiceal mucinous neoplasms: update on the contribution of imaging to choice of surgical approach].
    Gillion JF, Franco D, Chapuis O, Serpeau D, Convard JP, Jullès MC, Balaton A, Karkouche B, Capelle P, Parmentier T, Chollet JM, Thillois JM, Berthelot G.
    J Chir (Paris); 2009 Apr 10; 146(2):150-66. PubMed ID: 19552906
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Prognostic value of clinical and pathological characteristics in 48 women with pseudomyxoma peritonei].
    Lu YY, Guo AT, Liu AJ, Shi HY.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug 10; 48(8):595-601. PubMed ID: 24199925
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
    Sørensen O, Flatmark K, Reed W, Wiig JN, Dueland S, Giercksky KE, Larsen SG.
    Eur J Surg Oncol; 2012 Oct 10; 38(10):969-76. PubMed ID: 22763244
    [Abstract] [Full Text] [Related]

  • 15. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH.
    Eur J Surg Oncol; 2001 Apr 10; 27(3):239-43. PubMed ID: 11373099
    [Abstract] [Full Text] [Related]

  • 16. Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).
    Chen CF, Huang CJ, Kang WY, Hsieh JS.
    World J Surg Oncol; 2008 Nov 11; 6():118. PubMed ID: 19014441
    [Abstract] [Full Text] [Related]

  • 17. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb 11; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 18. Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms.
    Menassel B, Duclos A, Passot G, Dohan A, Payet C, Isaac S, Valette PJ, Glehen O, Rousset P.
    Eur J Surg Oncol; 2016 Apr 11; 42(4):558-66. PubMed ID: 26856956
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
    Järvinen P, Ristimäki A, Kantonen J, Lepistö A.
    Scand J Surg; 2013 Apr 11; 102(3):145-51. PubMed ID: 23963027
    [Abstract] [Full Text] [Related]

  • 20. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
    Marcotte E, Dubé P, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Sideris L.
    World J Surg Oncol; 2014 Nov 07; 12():332. PubMed ID: 25380618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.